The most frequent antibodies are CV2/CRMP5,30 amphiphysin,31 and PCA-2/microtubule-associated protein 1B,57 usually in the context of SCLC, or breast cancer also in association with amphiphysin antibodies. Here, MAP1B is linked to breast cancer.